news Archives - Page 68 of 100 - Journal for Clinical Studies

Current Edition

news

Pegfilgrastim Biosimilar Matches Reference Product

Sandoz's biosimilar of Neulasta, or pegfilgrastim, matched the reference product in a clinical trial, according to the company. Researchers found equivalence in pharm...

20 December 2017 news biosimilar | cancer

Continue Reading →

news

Discontinuation of Sanofi’s C. difficile Vaccine Program presents an opportunity for Pfizer and Valneva, observes GlobalData

On December 1 2017, Sanofi Pasteur announced its intention to discontinue the Phase III development program for its Clostridium difficile vaccine. The vaccine was on ...

20 December 2017 news clostridium difficile | late-stage clinical

Continue Reading →

news

British trial results promising for Huntington’s drug

UCL scientists have successfully completed the first human trial of the drug that targets the cause of Huntington’s disease. After over a decade in pre-clinical devel...

20 December 2017 news human trial | Huntington

Continue Reading →

news

LaJolla Pharma launches mid-stage study of LJPC-401 in iron overload disorder

LaJolla Pharmaceuticals initiates a Phase 2 clinical trial assessing LJPC-401 (synthetic human hepcidin) in patients with hereditary hemochromatosis, a deficiency of ...

20 December 2017 news hemochromatosis | hepcidin

Continue Reading →

news

Targovax announces that TG02 has passed the initial safety review in the first-in-man clinical trial in colorectal cancer

Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces that TG02 has passed the in...

20 December 2017 news clinical trial | immuno-oncology

Continue Reading →

news

FDA lifts clinical hold on fitusiran

Sanofi Genzyme, the specialty care global business unit of Sanofi, and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced ...

20 December 2017 news clinical study | FDA

Continue Reading →

news

Hovione Announces Enrollment of First Patient in MARS, a Phase 2 Clinical Trial for the Treatment of Moderate to Severe Inflammatory Rosacea with its Proprietary Minocycline Topical Gel

Hovione announced today enrollment of the first patient in MARS (Minocycline Against Rosacea Study), a Phase 2 clinical study of topical minocycline (HY01) in moderat...

14 December 2017 news enrollment | MARS

Continue Reading →

news

argenx reports positive topline results from Phase 2 proof-of-concept trial of ARGX-113 (efgartigimod) in generalized myasthenia gravis

argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment o...

13 December 2017 news antibody | autoimmune

Continue Reading →

news

CTI Clinical Trial, Consulting Services Announces Acquisition Of Eurotrials

CTI Clinical Trial and Consulting Services announced the acquisition of Eurotrials, a full-service contract research organization, with more than 20 years of experien...

13 December 2017 news acquisition | clinical trial

Continue Reading →

news

CRISPR Therapeutics Announces Planned European Clinical Trial

CRISPR Therapeutics today announced the submission of a Clinical Trial Application (CTA) today for CTX001 in β-thalassemia. CTX001 is an investigational CRISPR gene-e...

13 December 2017 news application | clinical trial

Continue Reading →